Search filters

A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 31 December 2013
Author/s

author: Ajay K Gopal  Ian W. Flinn 

Publication date December 31, 2013
Language English
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item